Fiche centre
The First Affiliated Hospital of Bengbu Medical College
Bengbu — China
Essais liés5clinical trials
VilleBengbulocalisation
PaysChinalocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT05152147
Essais cliniques associés
5| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Qishen Yiqi dripping pills 4 bags/time | Insuffisance cardiaque | Phase 2 | NCT04944706 | Efficacy and Safety of Qishenyiqi Dripping Pills for Treating Chronic Heart Failure With Preserved Ejection Fraction | COMPLETED |
| Zanidatamab | Parkinson | Phase 3 | NCT05152147 | HERIZON-GEA-01 — A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers | ACTIVE_NOT_RECRUITING |
| Budoprutug | Lupus | Phase 1/2 | NCT07564596 | A Phase 1b/2a Study of Budoprutug in Systemic Lupus Erythematosus (SLE) | RECRUITING |
| SG301 SC Injection | Lupus | Phase 1 | NCT06144710 | SG301-SC Injection Safety Study in Subjects With Systemic Lupus Erythematosus | COMPLETED |
| Telitacicept | Lupus | Phase 1 | NCT05247203 | Telitacicept Study in Chinese Subjects With Systemic Lupus Erythematosus | COMPLETED |